tradingkey.logo

Alpha Teknova Inc

TKNO
4.710USD
-0.100-2.08%
Cierre 11/07, 16:00ETCotizaciones retrasadas 15 min
252.05MCap. mercado
PérdidaP/E TTM

Alpha Teknova Inc

4.710
-0.100-2.08%

Más Datos de Alpha Teknova Inc Compañía

Alpha Teknova, Inc. is a producer of critical reagents for the research, discovery, development, and commercialization of therapies, vaccines, and molecular diagnostics. It offers two primary business lines, which include lab essentials and clinical solutions. It also offers three primary product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. The Company offers its liquid cell culture media and supplements and molecular biology reagents in both of its two product categories; pre-poured media plates are available in its Lab Essentials category only. Its customers include pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostics franchises, and academic and government research institutions developing vaccines and therapies and performing basic research.

Información de Alpha Teknova Inc

Símbolo de cotizaciónTKNO
Nombre de la empresaAlpha Teknova Inc
Fecha de salida a bolsaJun 25, 2021
Director ejecutivoMr. Stephen Gunstream
Número de empleados173
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 25
Dirección2451 Bert Drive
CiudadHOLLISTER
Bolsa de valoresNASDAQ Global Market Consolidated
PaísUnited States of America
Código postal95023
Teléfono18316371100
Sitio Webhttps://www.teknova.com/
Símbolo de cotizaciónTKNO
Fecha de salida a bolsaJun 25, 2021
Director ejecutivoMr. Stephen Gunstream

Ejecutivos de Alpha Teknova Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Irene Davis
Ms. Irene Davis
Director
Director
1.69M
--
Mr. Stephen Gunstream
Mr. Stephen Gunstream
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
243.50K
+13.39%
Mr. Alexander Vos
Mr. Alexander Vos
Independent Director
Independent Director
126.72K
+74.98%
Mr. Damon Terrill
Mr. Damon Terrill
Chief Compliance Officer, General Counsel
Chief Compliance Officer, General Counsel
41.03K
--
Ms. Martha J. Demski
Ms. Martha J. Demski
Independent Director
Independent Director
25.07K
-24.19%
Dr. Paul D. Grossman
Dr. Paul D. Grossman
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
9.21K
--
Alex Herzick
Alex Herzick
Director
Director
--
--
Ms. Brett M. Robertson
Ms. Brett M. Robertson
Independent Director
Independent Director
--
--
Mr. J. Matthew Mackowski
Mr. J. Matthew Mackowski
Director
Director
--
--
Mr. Matthew C. Lowell
Mr. Matthew C. Lowell
Chief Financial Officer
Chief Financial Officer
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Irene Davis
Ms. Irene Davis
Director
Director
1.69M
--
Mr. Stephen Gunstream
Mr. Stephen Gunstream
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
243.50K
+13.39%
Mr. Alexander Vos
Mr. Alexander Vos
Independent Director
Independent Director
126.72K
+74.98%
Mr. Damon Terrill
Mr. Damon Terrill
Chief Compliance Officer, General Counsel
Chief Compliance Officer, General Counsel
41.03K
--
Ms. Martha J. Demski
Ms. Martha J. Demski
Independent Director
Independent Director
25.07K
-24.19%
Dr. Paul D. Grossman
Dr. Paul D. Grossman
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
9.21K
--

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Lab Essentials
7.79M
75.75%
Clinical Solutions
2.06M
20.03%
Other
435.00K
4.23%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
9.78M
95.04%
International
510.00K
4.96%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Lab Essentials
7.79M
75.75%
Clinical Solutions
2.06M
20.03%
Other
435.00K
4.23%

Estadísticas de accionistas

Actualizado: hace 11 minutos
Actualizado: hace 11 minutos
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Telegraph Hill Partners
70.48%
Davis (Ted)
3.53%
Davis (Irene)
3.15%
UBS Financial Services, Inc.
2.96%
Balyasny Asset Management LP
1.87%
Otro
18.01%
Accionistas
Accionistas
Proporción
Telegraph Hill Partners
70.48%
Davis (Ted)
3.53%
Davis (Irene)
3.15%
UBS Financial Services, Inc.
2.96%
Balyasny Asset Management LP
1.87%
Otro
18.01%
Tipos de accionistas
Accionistas
Proporción
Private Equity
70.48%
Individual Investor
10.72%
Investment Advisor
6.61%
Investment Advisor/Hedge Fund
4.37%
Hedge Fund
2.90%
Research Firm
1.00%
Pension Fund
0.04%
Bank and Trust
0.03%
Otro
3.85%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
142
45.72M
85.43%
-1.12M
2025Q2
134
49.86M
93.29%
-910.00K
2025Q1
159
49.02M
94.72%
+9.59M
2024Q4
142
49.19M
92.33%
+11.09M
2024Q3
142
47.90M
89.93%
+8.81M
2024Q2
140
36.69M
87.73%
-3.53M
2024Q1
145
36.60M
90.14%
-2.50M
2023Q4
149
35.47M
91.35%
-3.28M
2023Q3
155
35.09M
90.51%
+4.53M
2023Q2
176
26.14M
92.65%
-5.67M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Telegraph Hill Partners
37.72M
70.48%
--
--
Apr 22, 2025
Davis (Ted)
1.89M
3.53%
--
--
Apr 22, 2025
Davis (Irene)
1.69M
3.15%
--
--
Apr 22, 2025
UBS Financial Services, Inc.
1.58M
2.96%
+424.17K
+36.58%
Jun 30, 2025
Balyasny Asset Management LP
1.00M
1.87%
+163.53K
+19.54%
Jun 30, 2025
Mackowski J Matthew
820.81K
1.53%
--
--
Apr 22, 2025
Lowell (Matthew)
820.81K
1.53%
+701.77K
+589.51%
Apr 22, 2025
The Vanguard Group, Inc.
652.18K
1.22%
+78.74K
+13.73%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
615.90K
1.15%
+480.11K
+353.57%
Jun 30, 2025
Roubaix Capital, LLC
439.94K
0.82%
+439.94K
--
Jun 30, 2025
Ver más

ETFs relacionados

Actualizado: jue., 6 de nov
Actualizado: jue., 6 de nov
Nombre
Proporción
ProShares Nanotechnology ETF
0.78%
Invesco Nasdaq Biotechnology ETF
0.03%
ProShares Ultra Nasdaq Biotechnology
0.03%
iShares Biotechnology ETF
0.01%
iShares Micro-Cap ETF
0.01%
iShares Russell 2000 Growth ETF
0%
Dimensional US Core Equity 1 ETF
0%
iShares Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
ProShares UltraPro Russell2000
0%
Ver más
ProShares Nanotechnology ETF
Proporción0.78%
Invesco Nasdaq Biotechnology ETF
Proporción0.03%
ProShares Ultra Nasdaq Biotechnology
Proporción0.03%
iShares Biotechnology ETF
Proporción0.01%
iShares Micro-Cap ETF
Proporción0.01%
iShares Russell 2000 Growth ETF
Proporción0%
Dimensional US Core Equity 1 ETF
Proporción0%
iShares Russell 2000 ETF
Proporción0%
Proshares Ultra Russell 2000
Proporción0%
ProShares UltraPro Russell2000
Proporción0%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI